AIG
LEGN icon

American International Group’s Legend Biotech LEGN Stock Holding History

American International Group’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-900
Closed -$50.5K – 1477
2024
Q1 		$50.5K Buy
900
+300
+50% +$18.1K ﹤0.01% 2778
2023
Q4 		$36.1K Hold
600
– – ﹤0.01% 2882
2023
Q3 		$40.3K Hold
600
– – ﹤0.01% 2871
2023
Q2 		$41.4K Hold
600
– – ﹤0.01% 2930
2023
Q1 		$28.9K Hold
600
– – ﹤0.01% 2842
2022
Q4 		$30K Hold
600
– – ﹤0.01% 2866
2022
Q3 		$24K Hold
600
– – ﹤0.01% 2958
2022
Q2 		$33K Buy
+600
New +$25.3K ﹤0.01% 2952

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

American International Group's LEGN Position: Q2 2024 in Review

American International Group sold out of Legend Biotech (LEGN) in Q2 2024, closing a stake of 900 shares — an estimated $50.5K sold.

American International Group first reported a position in LEGN in Q2 2022 and held it in 8 quarters. The position peaked at $50.5K in Q1 2024. 181 funds tracked by Wall St. Rank hold LEGN as of Q2 2024.

  • American International Group reported no remaining Legend Biotech position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 900 Legend Biotech shares in Q2 2024, an estimated $50.5K.
  • American International Group first reported a position in Legend Biotech in Q2 2022 and held it in 8 quarters.
  • American International Group's Legend Biotech position peaked at $50.5K in Q1 2024.
  • 181 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.